$92.53Million | No. of Holdings #3
Crestline Management, LP Performance
| Ticker | % Inc. |
|---|---|
| 8x8 inc new | 100 |
| denali therapeutics inc | 57.31 |
| sana biotechnology inc | 23.8 |
Crestline Management, L.P. has about 96.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 96.4 |
| Technology | 3.6 |
Crestline Management, L.P. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 91.7 |
| SMALL-CAP | 8.3 |
About 100% of the stocks held by Crestline Management, L.P. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 100 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Crestline Management, L.P. has 3 stocks in it's portfolio. SANA proved to be the most loss making stock for the portfolio. DNLI was the most profitable stock for Crestline Management, L.P. last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Denali Therapeutics Inc Crestline Management, LP's holding in Denali Therapeutics Inc over time | 91.74% | 4,421,460 | $84.89M 91.74% | 57.31%increased 57.31 percentadded | |
8x8 Inc New 8x8 Inc NewEGHT Crestline Management, LP's holding in 8x8 Inc New over time | 3.56% | 1,981,700 | $3.29M 3.56% | 100.05%increased 100.05 percentadded | |
Sana Biotechnology Inc Crestline Management, LP's holding in Sana Biotechnology Inc over time | 4.7% | 1,511,470 | $4.35M 4.7% | 23.8%increased 23.8 percentadded | |